HLPMF yields 4.51% · MRK yields 2.76%● Live data
📍 HLPMF pulled ahead of the other in Year 1
Combined, HLPMF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HLPMF + MRK for your $10,000?
HELLENiQ ENERGY Holdings S.A., together with its subsidiaries, operates in the energy sector primarily in Greece, South Eastern Europe, and the East Mediterranean. It operates through the Refining, Marketing, Exploration and Production of Hydrocarbons, Petro-chemicals, Gas and Power, and Other segments. The company engages in the refining, supply, and trading of petroleum products; marketing of fuels; production and trading of petrochemicals/chemicals; exploration and production of oil and gas; and generation and trading of power. It is also involved in the production, distribution, and trading of renewable energy sources; provision of financing and other financial services; retail trade of liquid fuels and LPG; operation of tankers; exploration and production of hydrocarbons; trade, distribution, and storage of oil products; and construction and operation of crude oil pipelines. In addition, the company engages in the owning of vessels; production and marketing of lubricants, polypropylene, and solvents; trading of imported plastics and chemicals; production and trade of BOPP films; construction and operation of fuel storage facilities; and provision of treasury, consulting, and engineering services. It operates a network of 1,682 service stations, 15 fuel storage and distribution facilities, 24 aircraft refueling stations in the Greek airports, 2 LPG bottling plants, and 1 lubricant production and packing site in Greece. The company was formerly known as Hellenic Petroleum Holdings Societe Anonyme and changed its name to HELLENiQ ENERGY Holdings S.A. in September 2022. HELLENiQ ENERGY Holdings S.A. was founded in 1998 and is headquartered in Marousi, Greece.
Full HLPMF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.